BRPI0419023A - vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio - Google Patents

vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio

Info

Publication number
BRPI0419023A
BRPI0419023A BRPI0419023-8A BRPI0419023A BRPI0419023A BR PI0419023 A BRPI0419023 A BR PI0419023A BR PI0419023 A BRPI0419023 A BR PI0419023A BR PI0419023 A BRPI0419023 A BR PI0419023A
Authority
BR
Brazil
Prior art keywords
meningitis
sabin
vaccine
hepatitis
derived
Prior art date
Application number
BRPI0419023-8A
Other languages
English (en)
Inventor
Rajesh Jain
Anil Chawla
Ganesh Kumraj
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of BRPI0419023A publication Critical patent/BRPI0419023A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

VACINA CONTRA POLIOMIELITE INATIVADA E DERIVADA DO GêNERO SABIN DE VìRUS DA PóLIO. A presente invenção refere-se a uma vacina contra Pólio Inativada derivada do gênero Sabin para imunização segura e eficaz contra poliomielite é proporcionada. Um processo para o preparo de tal vacina e formulações da mesma são também proporcionados, administração da vacina da presente invenção junto com outros antígenos proporciona imunização não apenas contra infecção pólio, mas também contra outros patógenos que causam Hepatite C, Hepatite D, Hepatite E, Meningite A, Meningite B, Meningite C, Meningite W, Meningite Y, Pneumocócica (23 valente ou mais), Varíola, Tifóide, Bacilo de Calmette Guerin, Tuberculose, Vírus da Imunodeficiência Humana, Antrax ou semelhante, aos quais crianças ou adultos não imunizados previamente são suscetíveis, particularmente aos quais crianças são suscetíveis.
BRPI0419023-8A 2004-08-27 2004-08-27 vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio BRPI0419023A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2004/000267 WO2007007344A1 (en) 2004-08-27 2004-08-27 Inactivated poliomyelitis vaccine derived from sabin strain of polio virus

Publications (1)

Publication Number Publication Date
BRPI0419023A true BRPI0419023A (pt) 2007-12-11

Family

ID=34958659

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0419023-8A BRPI0419023A (pt) 2004-08-27 2004-08-27 vacina contra poliomielite inativada e derivada do genero sabin de vìrus da polio

Country Status (7)

Country Link
US (1) US20080193478A1 (pt)
EP (1) EP1793852A1 (pt)
BR (1) BRPI0419023A (pt)
EA (1) EA010057B1 (pt)
MX (1) MX2007002372A (pt)
RS (1) RS20070078A (pt)
WO (1) WO2007007344A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101617464B1 (ko) 2006-09-29 2016-05-02 잇판사이단호진한다이비세이부쯔뵤우겐큐우카이 Ｉｐｖ―ｄｐｔ 백신
PE20100365A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
GB0822633D0 (en) 2008-12-11 2009-01-21 Novartis Ag Formulation
AU2010272685B2 (en) 2009-07-16 2015-02-26 Crucell Holland B.V. Production of polio virus at high titers for vaccine production
RU2013136397A (ru) * 2011-01-05 2015-02-10 Бхарат Байотек Интернэшнл Лимитед Комбинированная семивалентная вакцина
JP2015500864A (ja) * 2011-12-23 2015-01-08 ノバルティス アーゲー 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物
EA201891945A3 (ru) 2012-08-01 2019-05-31 Бавариан Нордик А/С Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
PT3010537T (pt) * 2013-06-17 2019-12-03 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport Métodos para a prevenção da agregação de componentes virais
US10238730B2 (en) 2014-06-17 2019-03-26 Janssen Vaccines & Prevention B.V. Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains
DK3172317T3 (da) 2014-07-24 2019-07-22 Janssen Vaccines & Prevention Bv Fremgangsmåde til oprensning af poliovirus fra cellekulturer
EP3204494B1 (en) * 2014-10-07 2020-04-01 Serum Institute Of India Private Limited Improved methods for poliovirus inactivation, adjuvant adsorption
CA3081586A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
CN116983398A (zh) 2017-11-30 2023-11-03 武田疫苗股份有限公司 寨卡疫苗和免疫原性组合物以及其使用方法
EP3749757A4 (en) * 2018-02-07 2021-11-24 Bharat Biotech International Limited PROCESS FOR PURIFICATION AND INACTIVATION OF ENTERVIRUSES AND VACCINE COMPOSITIONS OBTAINED THEREOF
ES2988154T3 (es) * 2020-04-11 2024-11-19 Qiyi Xie Vacunación contra coronavirus con vacuna de poliomielitis
US20210322542A1 (en) * 2020-04-11 2021-10-21 Qiyi Xie Vaccination against coronavirus with poliomyelitis vaccine
CN115747177B (zh) * 2022-11-25 2026-04-07 金宇保灵生物药品有限公司 一种灭活病毒的方法与应用

Also Published As

Publication number Publication date
WO2007007344A1 (en) 2007-01-18
EP1793852A1 (en) 2007-06-13
RS20070078A (sr) 2008-11-28
EA200700496A1 (ru) 2007-10-26
US20080193478A1 (en) 2008-08-14
EA010057B1 (ru) 2008-06-30
MX2007002372A (es) 2007-05-08

Similar Documents

Publication Publication Date Title
TW200722101A (en) Novel composition
JP2009539965A5 (pt)
SA521430813B1 (ar) لقاح وحدات فرعية لعلاج عدوى الجهاز التنفسي أو الوقاية منها
SI2097102T1 (sl) Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
ATE499113T1 (de) Influenzavirus-impfstoffzusammensetzung
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
BR9910749A (pt) Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
BRPI0508813A (pt) vacinas de combinação com baixa dose de conjugado de hib
WO2009032913A3 (en) Thermal inactivation of rotavirus
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
MX2010006984A (es) Vacunas contra la malaria.
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
Jones et al. A nasal Proteosome™ influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity
EA201170238A1 (ru) Эпитопная вакцина для предотвращения и сдерживания развития болезни альцгеймера
EP1301208A4 (en) Vaccine
JP2009514840A5 (pt)
ATE547116T1 (de) Kombinationsimpfstoff
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
ZA202306249B (en) Use of vaccine compositions based on sars-cov-2 receptor binding domain in delivering protective immunity
WO2021216560A3 (en) Vaccine compositions for sars-related coronaviruses and methods of use
WO2005097179A3 (fr) Antigene tat stabilise et ses applications pour la vaccination anti-vih.
UY31574A1 (es) Vacunas contra la malaria
EA201070014A1 (ru) Внутрикожная вакцина против гриппа

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.